Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population

Schizophrenia Research
Danielle KamisGabriel A de Erausquin

Abstract

We tested the hypothesis that loss of substantia nigra neurons in subjects at risk of schizophrenia (1), as reflected by midbrain hyperechogenicity (2) and parkinsonian motor impairment (3), is asymmetric and influenced by sex. We evaluated 62 subjects with never-treated chronic schizophrenia, 80 of their adult, unaffected first degree relatives and 62 healthy controls (matched by sex and age to the cases), part of an Andean population of Northern Argentina. Parkinsonism was scored blindly using UPDRS-3 (Unified Parkinson's Disease Rating Scale) on videotaped exams by 2 independent raters. Transcranial ultrasound was performed by an expert sonographist blind to subject condition with a 2.5 MHz transducer through a temporal bone window. Quantification of echogenic area was carried out on saved images by a different evaluator. We found a significant difference in parkinsonian motor impairment between patients, their relatives as well as controls. All three groups showed worse parkinsonism on the left side than the right, corresponding with increased echogenicity on the right substantia nigra compared with the left. Females had significantly more right echogenicity than males, and patients and unaffected relatives were significant...Continue Reading

References

May 1, 1990·Brain Research. Developmental Brain Research·I ReisertC Pilgrim
Jan 1, 1988·Schizophrenia Bulletin·D R Weinberger, K F Berman
Sep 1, 1993·The American Journal of Psychiatry·M P CaligiuriD V Jeste
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·A BreierD Pickar
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M F EganD R Weinberger
Jun 20, 2003·European Psychiatry : the Journal of the Association of European Psychiatrists·Burkhard Emanuel JabsBruno Pfuhlmann
May 5, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Kathryn M Abel
Jul 29, 2004·Schizophrenia Bulletin·Martin KnappJudit Simon
Feb 24, 2005·Journal of Psychiatric Research·Robin G McCreadieRangaswamy Thara
Mar 15, 2006·Apoptosis : an International Journal on Programmed Cell Death·D A DorseyG A de Erausquin
Sep 19, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·A J EspayA E Lang
Sep 7, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Paul J Harrison, Elizabeth M Tunbridge
Sep 19, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mary F Kritzer, Lela M Creutz
Feb 9, 2010·Journal of Neuroendocrinology·M L JohnsonC M Kuhn
Nov 5, 2010·International Review of Psychiatry·Kathryn M AbelJill M Goldstein
Oct 9, 2012·Brain : a Journal of Neurology·Christoph ScherflerWerner Poewe
Aug 27, 2013·Psychiatry Research·Chiara ChiapponiGianfranco Spalletta

❮ Previous
Next ❯

Citations

Jun 18, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Andrea SchmittUNKNOWN WFSBP Task Force on Biological Markers
Mar 3, 2020·Psychological Medicine·Manuel J CuestaVictor Peralta
Oct 4, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Carsten DrepperManfred Gerlach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.